![]() |
Technical Data |
|
C0026-11N1 |
c-erbB2 (HER-2, neu Receptor) |
|
|
Description: c-erbB-2 is the cellular homolog of the neu oncogene. c-erbB-2 is comprised of an extracellular ligand binding domain, a single transmembrane domain, a tyrosine kinase domain, and a C terminal region which mediates signaling. c-erbB-2 forms heterodimers with other members of the EGF receptor family, such as c-erbB-1. In response to ligand binding, c-erbB-2 is autophosphorylated on five tyrosine residues at its C terminus, producing docking sites for SH2-domain containing proteins such as phospholipase C , PI3-K, Src, CHK, and others. Over-expression of c-erbB-2 is observed in 15-40% of primary human breast tumors, and correlates with poor prognosis in node positive breast cancer. c-erbB-2 over-expression is also observed in ovarian, gastric, salivary, and non-small cell lung carcinomas. Applications: Suitable for use in Immunoprecipitation, Western Blot, ELISA, Flow Cytometry and Immunohistochemistry. Other applications not tested. Recommended Dilution: Immunoprecipitation (native and denatured): 2ug/mg cell lysate Western Blot: 1-2ug/ml with 2 hour incubation Immunohistochemistry (Formalin fixed paraffin embedded): 2-4ug/ml with 30 minute incubation. Requires boiling the sections in 10mM citrate buffer, pH 6.0 for 10-20 minutes, cool at RT for 10 minutes. Optimal dilutions to be determined by the researcher. Positive Control: SKBR-3 cells (breast cancer cell line), T47D cells. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. |
|
|||||||||||
|
||||||||||||
|
||||||||||||
|
||||||||||||